ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,556Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 298

$334K Total Retail Price of All Prescriptions

Rank: 86 out of 298

307 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 307 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,143 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 387 385 1 1
LISINOPRIL 362 328 2 4
WARFARIN SODIUM 360 358 3 7
OMEPRAZOLE 346 331 4 3
SIMVASTATIN 319 319 5 2
ATENOLOL 274 258 6 16
AMLODIPINE BESYLATE 258 254 7 6
FUROSEMIDE 246 236 8 5
POTASSIUM CHLORIDE 209 209 9 11
METOPROLOL TARTRATE 198 174 10 9
CITALOPRAM HBR 162 160 11 17
GABAPENTIN 157 157 12 20
ALENDRONATE SODIUM 156 156 13 21
ATORVASTATIN CALCIUM 155 137 14 14
HYDROCODONE-ACETAMINOPHEN 148 145 S3 15 8
METOPROLOL SUCCINATE 145 145 16 12
NIFEDIPINE ER 112 100 17 130
DIOVAN 108 108 18 47
DIGOXIN 102 93 19 27
LANTUS 98 98 20 53
LOSARTAN POTASSIUM 96 96 21 18
HYDROCHLOROTHIAZIDE 90 89 22 13
SERTRALINE HCL 90 86 22 19
ZOLPIDEM TARTRATE 86 86 24 25
DILTIAZEM 24HR CD 86 86 24 74
CARBIDOPA-LEVODOPA 84 84 26 49
DONEPEZIL HCL 82 82 27 22
CLOPIDOGREL 77 77 28 36
OXYBUTYNIN CHLORIDE 72 72 29 81
TRIAMTERENE-HCTZ 71 65 30 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 57 31 30
GEMFIBROZIL 68 68 32 65
ADVAIR DISKUS 67 65 33 46
EVISTA 63 63 34 134
FLUTICASONE PROPIONATE 61 55 35 38
GLIPIZIDE XL 58 49 36 92
MIRTAZAPINE 58 58 36 37
PLAVIX 55 55 38 70
AGGRENOX 53 53 39 178
PAROXETINE HCL 51 51 40 48
VERAPAMIL ER 51 49 40 88
CARVEDILOL 50 50 42 23
TRAMADOL HCL 50 49 42 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.